- Home
- ECVT vs ALMR Comparison
ECVT vs ALMR Comparison
Compare ECVT & ALMR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | ECVT | ALMR |
|---|---|---|
| Founded | 1935 | N/A |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Major Chemicals | Biotechnology: Laboratory Analytical Instruments |
| Sector | Industrials | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.3B | 1.5B |
| IPO Year | 2017 | 2026 |
Fundamental Metrics
Financial Performance| Metric | ECVT | ALMR |
|---|---|---|
| Price | $12.46 | $25.85 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 5 | 0 |
| Target Price | ★ $14.00 | N/A |
| AVG Volume (30 Days) | ★ 1.4M | 245.3K |
| Earning Date | 05-05-2026 | N/A |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | ★ 0.04 | N/A |
| Revenue | ★ $723,515,000.00 | N/A |
| Revenue This Year | $29.07 | N/A |
| Revenue Next Year | $6.71 | N/A |
| P/E Ratio | $311.50 | ★ N/A |
| Revenue Growth | ★ 2.70 | N/A |
| 52 Week Low | $7.41 | $21.58 |
| 52 Week High | $15.09 | $29.43 |
Technical Indicators
Market Signals| Indicator | ECVT | ALMR |
|---|---|---|
| Relative Strength Index (RSI) | 48.28 | 57.19 |
| Support Level | $11.62 | $23.88 |
| Resistance Level | $13.20 | $29.06 |
| Average True Range (ATR) | 0.37 | 1.90 |
| MACD | 0.11 | -0.18 |
| Stochastic Oscillator | 50.59 | 42.16 |
Price Performance
Historical ComparisonAbout ECVT Ecovyst Inc.
Ecovyst Inc is an integrated and provider of materials, specialty catalysts and services. Its products contribute to lower emissions and cleaner air, higher fuel efficiency and cleaner fuels, and key enablers to advance transition to clean energy. The company has one operating segment. The Company's single reportable segment, Ecoservices, derives its revenue through the sale of virgin and regenerated sulfuric acid products and services.
About ALMR Alamar Biosciences Inc. Common Stock
Alamar Biosciences Inc is a proteomics company engaged in protein detection and analysis. The company has developed its own NULISA (NUcleic Acid Linked Immuno-Sandwich Assay) technology as the foundation of its Precision Proteomics platform enabling the detection and quantification of protein biomarkers in a single sample with ultra-high sensitivity and high specificity, even from very small volumes of biofluid. The company operates in single segment and focuses on developing a good sensitive proteomic liquid biopsy platform and sells instruments, consumables, and services based on this platform to enable early detection of diseases. The products of the company includes NULISAseq Panels, NULISAqpcr Assays, and others.